Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

by Tomas Baldassarre, Peter Truesdell, Andrew W. Craig
Published 2017-10-01

Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development

by Manar Hammood, Andrew W. Craig, Jeffrey V. Leyton
Published 2021-07-01

Dataset of STAT5A status in breast cancer

by Utpal K. Mukhopadhyay, Jamaica Cass, Leda Raptis, Andrew W. Craig, Véronique Bourdeau, Sonal Varma, Sandip Sen Gupta, Bruce E. Elliott, Gerardo Ferbeyre
Published 2016-06-01

Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models

by Daniel Newsted, Sunandan Banerjee, Kathleen Watt, Sarah Nersesian, Peter Truesdell, Levi L. Blazer, Lia Cardarelli, Jarrett J. Adams, Sachdev S. Sidhu, Andrew W. Craig
Published 2019-02-01